3Markman M. Toxicities of the platinum antineoplastic agents [ J ]. Expert Opin Drug Saf, 2003,2(6) : 597-607.
4Gamelin E, Gamelin L, Bossi L,et al. Clinical aspects and molecular basis of oxaliplatin neurotoxicity: current management and development of preventive measures[ J]. Semin Oncol, 2005,29 (5) : 21-33.
